|
|
|
|
LEADER |
00000cam a2200000Ma 4500 |
001 |
SCIDIR_ocn646756581 |
003 |
OCoLC |
005 |
20231117033226.0 |
006 |
m o d |
007 |
cr cn||||||||| |
008 |
750720s2000 caua ob 001 0 eng d |
010 |
|
|
|z 52013360
|
040 |
|
|
|a E7B
|b eng
|e pn
|c E7B
|d OCLCQ
|d UBY
|d N$T
|d IDEBK
|d OCLCQ
|d OPELS
|d OCLCQ
|d OCLCF
|d OCLCQ
|d EBLCP
|d OCLCQ
|d DEBSZ
|d D6H
|d LEAUB
|d OCLCQ
|d SFB
|d INARC
|d OCLCO
|d OCLCQ
|d OCLCO
|
019 |
|
|
|a 276720484
|a 505094152
|a 945608846
|a 1127180954
|a 1136219906
|a 1162006009
|
020 |
|
|
|a 9780080562599
|q (electronic bk.)
|
020 |
|
|
|a 0080562590
|q (electronic bk.)
|
020 |
|
|
|a 0120066785
|q (electronic bk.)
|
020 |
|
|
|a 9780120066780
|q (electronic bk.)
|
020 |
|
|
|a 1281709379
|
020 |
|
|
|a 9781281709370
|
020 |
|
|
|a 9786611709372
|
020 |
|
|
|a 6611709371
|
035 |
|
|
|a (OCoLC)646756581
|z (OCoLC)276720484
|z (OCoLC)505094152
|z (OCoLC)945608846
|z (OCoLC)1127180954
|z (OCoLC)1136219906
|z (OCoLC)1162006009
|
050 |
|
4 |
|a RC267
|b .A4578 2000eb
|
072 |
|
7 |
|a MED
|x 062000
|2 bisacsh
|
072 |
|
7 |
|a HEA
|x 039030
|2 bisacsh
|
082 |
0 |
4 |
|a 616.99/40072
|2 22
|
245 |
0 |
0 |
|a Advances in cancer research.
|n Volume 78 /
|c edited by George F. Vande Woude ; George Klein.
|
260 |
|
|
|a San Diego :
|b Academic Press,
|c 2000.
|
300 |
|
|
|a 1 online resource (vii, 345 pages) :
|b illustrations.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
490 |
1 |
|
|a Advances in Cancer Research ;
|v v. 78
|
504 |
|
|
|a Includes bibliographical references and index.
|
588 |
0 |
|
|a Print version record.
|
520 |
|
|
|a Advances in Cancer Research provides invaluable information on the exciting and fast-moving field of cancer research. Here once again, outstanding and original reviews are presented. Key Features * Cell Transformation by the E7 Oncoprotein of HPV Type 16: Interactions with Nuclear and Cytoplasmic Target Proteins * Tumor Invasion: Role of Growth Factor-Induced Cell Motility * Non-Enzymatic Interactions Between Proteinases and the Cell Surface: Novel Roles in Normal and Malignant Cell Physiology * Molecular Pathogenesis of AIDS-Associated Kaposi's Sarcoma: Growth and Apoptosis * Perspectives on Cancer Chemoprevention Research and Drug Development.
|
505 |
0 |
|
|a Front Cover; Advances in Cancer Research, Volume 78; Copyright Page; Contents; Contributors to Volume 78; Chapter 1. Cell Transformation by the E7 Oncoprotein of Human Papillomavirus Type 16: Interactions with Nuclear and Cytoplasmic Target Proteins; I. Background: The Role of Papillomaviruses in Human Cancer; II. Cellular E7-Binding Proteins; III. Modulation of Cellular Functions by E7; IV. The Role of HPV-16 E7 in Cell Proliferation and Immortalization; References; Chapter 2. Tumor Invasion: Role of Growth Facto-lnduced Cell Motility; I. Introduction; II. Tumor Invasiveness.
|
505 |
8 |
|
|a III. Cell MotilityIV. Motility in Tumor Invasion; V. Therapeutic Interventions; VI. Summary and Future Directions; References; Chapter 3. Nonenzymatic Interactions between Proteinases and the Cell Surface: Novel Roles in Normal and Malignant Cell Physiology; I. Introduction; II. Extracellular Matrix-Degrading Proteinases: Classification and Structural Features; III. Proteolysis-Independent Roles of Extracellular Matrix-Degrading Proteinases; IV. Conclusions and Perspectives; References; Chapter 4. Molecular Pathogenesis of AIDS-Associated Kaposi's Sarcoma: Growth and Apoptosis.
|
505 |
8 |
|
|a I. IntroductionII. Histopathogenesis; III. Clinical Features; IV. In Vitro and in Vivo Models; V. Molecular Mechanisms of Kaposi's Sarcoma Cell Growth; VI. Roles of Virus Infections in Kaposi's Sarcoma Development; VII. Apoptosis in Kaposi's Sarcoma Cells; VIII. Concluding Remarks and Therapeutic Implications; References; Chapter 5. Perspectives on Cancer Chemoprevention Research and Drug Development; I. Introduction; II. Nature of Carcinogenesis; III. Definition of Chemoprevention and Chemoprevention Agent Discovery; IV. Chemopreventive Agent Development.
|
505 |
8 |
|
|a V. Cancer Chemoprevention at Major Cancer Target SitesVI. Surrogate End Points in Defining Chemopreventive Efficacy-Importance of Evaluating Both Phenotypic and Genotypic Effects; VII. Major Issues and Challenges for Cancer Chemoprevention; References; Index.
|
546 |
|
|
|a English.
|
650 |
|
0 |
|a Cancer
|x Research.
|
650 |
|
0 |
|a Oncology, Experimental.
|
650 |
|
2 |
|a Neoplasms, Experimental
|0 (DNLM)D009374
|
650 |
|
6 |
|a Cancer
|x Recherche.
|0 (CaQQLa)201-0004697
|
650 |
|
6 |
|a Canc�erologie exp�erimentale.
|0 (CaQQLa)201-0049886
|
650 |
|
7 |
|a MEDICAL
|x Oncology.
|2 bisacsh
|
650 |
|
7 |
|a HEALTH & FITNESS
|x Diseases
|x Cancer.
|2 bisacsh
|
650 |
|
7 |
|a Cancer
|x Research
|2 fast
|0 (OCoLC)fst00845497
|
650 |
|
7 |
|a Oncology, Experimental
|2 fast
|0 (OCoLC)fst01045747
|
700 |
1 |
|
|a Klein, George.
|
700 |
1 |
|
|a Vande Woude, George F.
|
776 |
0 |
8 |
|i Print version:
|t Advances in cancer research. Volume 78.
|d San Diego : Academic Press, 2000
|w (DLC) 52013360
|
830 |
|
0 |
|a Advances in Cancer Research.
|
856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780120066780
|z Texto completo
|